PARK INNOVAARE SECURES THE FINANCING OF ITS NEW CAMPUS
PARK INNOVAARE is an innovation park next to the Paul Scherrer Institute PSI and its unique complex of large research facilities. It offers technology-driven...
More details More details4. ordentliche Generalversammlung der innovAARE AG
(This information is only available in German) Der PARK INNOVAARE markiert einen weiteren wichtigen Meilenstein in seiner Entwicklung: Die Finanzierung...
More detailsDr. Fabia Gozzo: an exceptional, creative, inventive, and innovative woman and entrepreneur
In a couple of weeks, London will welcome some of the world’s most innovative women from all sectors and backgrounds. The 21st Global Women Inventors,...
More detailsNovel Accelerators for Electron Diffraction workshop at PARK INNOVAARE
Understanding how matter creates life requires observing living cells with atomic detail. There are many ways to do so, but one possibility has been gaining...
More detailsWE ARE HIRING!
PARK INNIVAARE is an innovation park next to the Paul Scherrer Institute PSI. It offers academic spin-offs, innovative start-ups, SMEs and big companies,...
More detailsA platform to discuss high-level topics with the pharmaceutical industry
Novartis (Switzerland) and Alphora (Canada) joined the case study program conducted as part of the Second Annual Spring Pharmaceutical Synchrotron X-Ray...
More details“Winning the Swiss BIC has helped us broaden our network”
Nowadays, cities face the ever-rising challenge of ensuring security, be it a low crime rate, reliable infrastructure, or safe traffic. At the same time,...
More detailsSecuraxis is the winner of the "Swiss BIC of CERN Competition"
Nowadays, cities face the ever-rising challenge of ensuring security, be it a low crime rate, reliable infrastructure, or safe traffic. At the same time,...
More detailsPARTICLE ACCELERATOR TOOLBOX PART I: BUILDING ACCELERATOR
Particle accelerators are mighty complex machines. It takes decades and hundreds of highly-specialized experts to build and operate one. It is not surprising...
More detailsBIC of CERN Technologies calls for innovative ideas leveraging accelerator technologies
As of today, start-ups and spin-offs, as well as small high-tech companies, younger than two years, can apply to become the next Business Incubation Centre...
More detailsInterAx partners with Lundbeck to identify better pharmaceutical compounds
InterAx Biotech AG, a spin-off of the Paul Scherrer Institute PSI and ETH Zurich, based at PARK INNOVAARE, is building a proprietary systems biology platform...
More detailsExcelsus invites pharma companies to explore for free the possibilities of synchrotron X-ray powder diffraction
The second annual Spring Pharmaceutical Synchrotron X-Ray Powder Diffraction (SPS-XRPD-2) Workshop, organized together with the 16th Pharmaceutical Powder...
More details